Author

Omidreza Firuzi

Professor of Pharmacology, Director MNCRC, Shiraz University of Medical Sciences - Cited by 7,341 - Cancer Drug Discovery - Targeted cancer therapeutics - Cancer cell biology

Biography

Omidreza Firuzi currently works at the Medicinal and Natural Products Chemistry Research Center, Shiraz University of Medical Sciences. Omidreza does research in Cancer Research, Cell Biology and Molecular Biology. Their current project is "Discovery of inhibitors of MET receptor as anticancer agents".
Title
Cited by
Year
Oxidative stress in amyotrophic lateral sclerosis: pathophysiology and opportunities for pharmacological intervention
T Cunha-Oliveira, L Montezinho, C Mendes, O Firuzi, L Saso, PJ Oliveira, ...Oxidative medicine and cellular longevity 2020, 2020202
77
2020
Novel small molecule therapeutic agents for Alzheimer disease: Focusing on BACE1 and multi-target directed ligands
A Iraji, M Khoshneviszadeh, O Firuzi, M Khoshneviszadeh, N EdrakiBioorganic Chemistry 97, 103649, 2020202
63
2020
Discovery of a potent dual inhibitor of acetylcholinesterase and butyrylcholinesterase with antioxidant activity that alleviates Alzheimer-like pathology in old APP/PS1 mice
E Viayna, N Coquelle, M Cieslikiewicz-Bouet, P Cisternas, CA Oliva, ...Journal of Medicinal Chemistry 64 (1), 812-839, 2020202
35
2020
5, 6-Diphenyl triazine-thio methyl triazole hybrid as a new Alzheimer’s disease modifying agents
M Yazdani, N Edraki, R Badri, M Khoshneviszadeh, A Iraji, O FiruziMolecular diversity 24, 641-654, 2020202
32
2020
Prospects of targeting PI3K/AKT/mTOR pathway in pancreatic cancer
M Mortazavi, F Moosavi, M Martini, E Giovannetti, O FiruziCritical reviews in oncology/hematology 176, 103749, 202
22
2022
Combination of HGF/MET-targeting agents and other therapeutic strategies in cancer
F Moosavi, E Giovannetti, GJ Peters, O FiruziCritical Reviews in Oncology/hematology 160, 103234, 202
21
2021
Pancreatic cancer resistance conferred by stellate cells: looking for new preclinical models
PP Che, A Gregori, O Firuzi, M Dahele, P Sminia, GJ Peters, E GiovannettiExperimental hematology & oncology 9 (1), 1-3, 2020202
15
2020
Imidazopyridine hydrazone derivatives exert antiproliferative effect on lung and pancreatic cancer cells and potentially inhibit receptor tyrosine kinases including c-Met
T Damghani, F Moosavi, M Khoshneviszadeh, M Mortazavi, S Pirhadi, ...Scientific Reports 11 (1), 3644, 2021202
15
2021
Study of the mechanism of action, molecular docking, and dynamics of anticancer terpenoids from Salvia lachnocalyx
H Hadavand Mirzaei, AR Jassbi, S Pirhadi, O FiruziJournal of Receptors and Signal Transduction 40 (1), 24-33, 2020202
14
2020
Antidiabetic and cytotoxic polyhydroxylated oleanane and ursane type triterpenoids from Salvia grossheimii
S Zare, H Mirkhani, O Firuzi, N Moheimanian, M Asadollahi, S Pirhadi, ...Bioorganic chemistry 104, 104297, 2020202
11
2020
Antiproliferative effect, alteration of cancer cell cycle progression and potential MET kinase inhibition induced by 3, 4-dihydropyrimidin-2 (1H)-one C5 amide derivatives
F Moosavi, A Ebadi, M Mohabbati, T Damghani, M Mortazavi, R Miri, ...European Journal of Pharmacology 894, 173850, 2021202
10
2021
Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer’s disease
A Rastegari, M Safavi, F Vafadarnejad, Z Najafi, R Hariri, SNA Bukhari, ...Molecular Diversity, 1-20, 2022202
9
2022
Dammarane-type triterpenoid saponins from Salvia russellii Benth.
SH Ghoran, O Firuzi, M Asadollahi, H Stuppner, M Alilou, AR JassbiPhytochemistry 184, 112653, 2021202
9
2021
Antileishmanial and pharmacophore modeling of abietane-type diterpenoids extracted from the roots of Salvia hydrangea
S Zare, G Hatam, O Firuzi, A Bagheri, JN Chandran, B Schneider, C Paetz, ...Journal of Molecular Structure 1228, 12447, 2021202
9
2021
Synthesis and in vitro biological activity evaluation of novel imidazo [2, 1-B][1, 3, 4] thiadiazole as anti-alzheimer agents
S Azimi, O Firuzi, A Iraji, A Zonouzi, M Khoshneviszadeh, M Mahdavi, ...Letters in Drug Design & Discovery 17 (5), 610-617, 2020202
8
2020
Phytoconstituents from the aerial parts of Salvia dracocephaloides Boiss. and their biological activities
SH Ghoran, O Firuzi, AR JassbiJournal of Environmental Treatment Techniques 8 (4), 124-128, 2020202
7
2020
Diterpenoids from roots of salvia lachnocalyx; In-silico and in-vitro toxicity against human cancer cell lines
HH Mirzaei, O Firuzi, AR JassbiIranian Journal of Pharmaceutical Research: IJPR 19 (4), 85, 2020202
7
2020
5-Oxo-hexahydroquinoline Derivatives and Their Tetrahydroquinoline Counterparts as Multidrug Resistance Reversal Agents
O Shahraki, M Khoshneviszadeh, M Dehghani, M Mohabbati, M Tavakkoli, ...Molecules 25 (8), 1839, 2020202
6
2020
Cytotoxic furanosesquiterpenoids and steroids from Ircinia mutans sponges
F Heidary Jamebozorgi, M Yousefzadi, O Firuzi, M Nazemi, S Zare, ...Pharmaceutical Biology 9 (1), 73-81, 2021202
5
2021
Paclitaxel‐loaded polypeptide‐polyacrylamide nanomicelles overcome drug‐resistance by enhancing lysosomal membrane permeability and inducing apoptosis
S Abbasi, G Yousefi, A Tamaddon, O FiruziJournal of Biomedical Materials Research Part A 109 (1), 18-30, 2021202
5
2021

Referred From: https://scholar.google.com/citations?user=XT8hVRsAAAAJ&hl=en

Cited by
Citations 7341
h-index 45
i10-index 120
Open Access Journals